381 related articles for article (PubMed ID: 21664875)
1. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.
Felgentreff K; Perez-Becker R; Speckmann C; Schwarz K; Kalwak K; Markelj G; Avcin T; Qasim W; Davies EG; Niehues T; Ehl S
Clin Immunol; 2011 Oct; 141(1):73-82. PubMed ID: 21664875
[TBL] [Abstract][Full Text] [Related]
2. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
4. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Cicalese MP; Ferrua F; Castagnaro L; Pajno R; Barzaghi F; Giannelli S; Dionisio F; Brigida I; Bonopane M; Casiraghi M; Tabucchi A; Carlucci F; Grunebaum E; Adeli M; Bredius RG; Puck JM; Stepensky P; Tezcan I; Rolfe K; De Boever E; Reinhardt RR; Appleby J; Ciceri F; Roncarolo MG; Aiuti A
Blood; 2016 Jul; 128(1):45-54. PubMed ID: 27129325
[TBL] [Abstract][Full Text] [Related]
5. Severe combined immunodeficiencies.
Fischer A
Immunodefic Rev; 1992; 3(2):83-100. PubMed ID: 1554500
[TBL] [Abstract][Full Text] [Related]
6. Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.
Carbonaro DA; Zhang L; Jin X; Montiel-Equihua C; Geiger S; Carmo M; Cooper A; Fairbanks L; Kaufman ML; Sebire NJ; Hollis RP; Blundell MP; Senadheera S; Fu PY; Sahaghian A; Chan RY; Wang X; Cornetta K; Thrasher AJ; Kohn DB; Gaspar HB
Mol Ther; 2014 Mar; 22(3):607-622. PubMed ID: 24256635
[TBL] [Abstract][Full Text] [Related]
7. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
8. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
[TBL] [Abstract][Full Text] [Related]
9. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
Hirschhorn R; Yang DR; Insel RA; Ballow M
Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
[TBL] [Abstract][Full Text] [Related]
10. Highly variable clinical phenotypes of hypomorphic RAG1 mutations.
Avila EM; Uzel G; Hsu A; Milner JD; Turner ML; Pittaluga S; Freeman AF; Holland SM
Pediatrics; 2010 Nov; 126(5):e1248-52. PubMed ID: 20956421
[TBL] [Abstract][Full Text] [Related]
11. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
Ramsey WJ; Mullen CA; Blaese RM
Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
Adams SP; Wilson M; Harb E; Fairbanks L; Xu-Bayford J; Brown L; Kearney L; Madkaikar M; Bobby Gaspar H
Clin Immunol; 2015 Dec; 161(2):174-9. PubMed ID: 26255240
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
[No Abstract] [Full Text] [Related]
15. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
16. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online.
Arrendondo-Vega FX; Santisteban I; Notarangelo LD; El Dahr J; Buckley R; Roifman C; Conley ME; Hershfield MS
Hum Mutat; 1998; 11(6):482. PubMed ID: 10200056
[TBL] [Abstract][Full Text] [Related]
17. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases.
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Jaing TH; Shih YF; Tseng TY; Lin YL
Ann Med; 2014 Nov; 46(7):555-65. PubMed ID: 25109505
[TBL] [Abstract][Full Text] [Related]
18. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
Sponzilli I; Notarangelo LD
Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
[TBL] [Abstract][Full Text] [Related]
19. [Primary immunodeficiencies. Clinical features and variant forms].
Fontán Casariego G
Allergol Immunopathol (Madr); 2001; 29(3):101-7. PubMed ID: 11434882
[TBL] [Abstract][Full Text] [Related]
20. The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency.
Serana F; Sottini A; Chiarini M; Zanotti C; Ghidini C; Lanfranchi A; Notarangelo LD; Caimi L; Imberti L
J Immunol; 2010 Dec; 185(12):7713-22. PubMed ID: 21057082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
